U.S. Biopharmaceutical Cro Market Size & Outlook, 2025-2033

Name: U.S. Biopharmaceutical Cro Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The biopharmaceutical cro market in the United States is expected to reach a projected revenue of US$ 11,279.2 million by 2033. A compound annual growth rate of 8.8% is expected of the United States biopharmaceutical cro market from 2025 to 2033.

U.S. biopharmaceutical cro type outlook (Revenue, USD million, 2021-2033)
- Drug Discovery
  - Target Validation
  - Lead Identification
  - Lead Optimization
- Pre-Clinical
- Clinical
  - Phase I Trial Services
  - Phase II Trial Services
  - Phase III Trial Services
  - Phase IV Trial Services
U.S. biopharmaceutical cro product outlook (Revenue, USD million, 2021-2033)
- Monoclonal antibodies (mAbs)
- Recombinant proteins & enzymes
- Vaccines
- Cell & Gene Therapies
- Nucleic acid Therapeutics
- Others
U.S. biopharmaceutical cro service outlook (Revenue, USD million, 2021-2033)
- Project Management/Clinical Supply Management
- Data Management
- Regulatory/Medical Affairs
- Medical Writing
- Clinical Monitoring
- Quality Management/ Assurance
- Bio-statistics
- Investigator Payments
- Laboratory
- Patient And Site Recruitment
- Technology
- Others
U.S. biopharmaceutical cro therapeutic area outlook (Revenue, USD million, 2021-2033)
- Oncology
- CNS Disorders
- Infectious Diseases
- Immunological Disorders
- Cardiovascular Disease
- Respiratory Diseases
- Diabetes
- Ophthalmology
- Pain Management
- Others
U.S. biopharmaceutical cro end use outlook (Revenue, USD million, 2021-2033)
- Large Pharmaceutical & Biotechnology companies
- Small & Mid-Size Sponsors
- Academic & Government research

U.S. Biopharmaceutical Cro Market Size & Outlook, 2025-2033

Sign up - it's easy, and free!